Acknowledgements
The work has been made possible by support from the National Research
Foundation, NRF CSRU180429324830, The Harry Crossley Foundation,
University of Cape Town, and The Professor Bongani Mayosi Netcare
Clinical Scholarship.
Special thanks to Professor David Reynders and Ms Judy Schoeman of the
South African Children’s Tumour Registry as well as Mrs Felicity Douglas
and Ms Michelle Kannemeyer from the Red Cross War Memorial Children’s
Hospital in Cape Town. Dr Jaques van Heerden and the staff of the
Paediatric Haematology Oncology, Department of Paediatrics and Child
Health, Pietermaritzburg Metro Complex, University of Kwa-Zulu-Natal,
Pietermaritzburg, South Africa, are also acknowledged for their
participation in the study.